Differential Effects of 17β-Estradiol upon Stroke Damage in Stroke Prone and Normotensive Rats

We previously reported that during pro-estrus (high endogenous estrogen levels), brain damage after middle cerebral artery occlusion (MCAO) was reduced in stroke-prone spontaneously hypertensive rats (SHRSP) but not in normotensive Wistar Kyoto rat (WKY). In the present study, we examined the effect of exogenous estrogen on brain damage after MCAO in SHRSP and WKY. A 17β-estradiol (0.025mg or 0.25mg, 21 day release) or matching placebo pellet was implanted into ovariectomized WKY and SHRSP (3 to 4 months old) who then underwent distal diathermy-induced MCAO 2 weeks later. Plasma 17β-estradiol levels for placebo and 17β-estradiol groups were as follows: WKY 0.025 mg 16.4 ± 8.5 (pg/mL, mean ± SD) and 25.85 ± 12.6; WKY 0.25 mg 18.2 ± 9.0 and 69.8 ± 27.4; SHRSP 0.25 mg 20.7 ± 8.8 and 81.0 ± 16.9. In SHRSP, infarct volumes at 24 hours after MCAO were similar in placebo and 17β-estradiol groups: SHRSP 0.025 mg 126.7 ± 15.3 mm3 (n = 6) and 114.0 ± 14.1 mm3 (n = 8) (not significant); SHRSP 0.25 mg 113.5 ± 22.3 mm3 (n = 8) and 129.7 ± 26.2 mm3 (n = 7) (not significant), respectively. In WKY, 17β-estradiol significantly increased infarct volume by 65% with 0.025mg dose [36.1 ± 20.7 mm3 (n = 8) and 59.7 ± 19.3 mm3 (n = 8) (P = 0.033, unpaired t-test)] and by 96% with 0.25 mg dose [55.9 ± 36.4 mm3 (n = 8) and 109.7 ± 6.7 mm3 (n = 4) (P = 0.017)]. Thus, 17β-estradiol increased stroke damage in normotensive rats with no significant effect in stroke-prone rats. Despite being contrary to our hypothesis, our findings add substance to the recently reported negative effects of 17β-estradiol in clinical studies.

[1]  C. Woolley,et al.  Estrogen Regulates Functional Inhibition of Hippocampal CA1 Pyramidal Cells in the Adult Female Rat , 2001, The Journal of Neuroscience.

[2]  Y Q Zhang,et al.  Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. , 1997, Journal of neurosurgery.

[3]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Svend Kreiner,et al.  Hormone replacement therapy and risk of non-fatal stroke , 1997, The Lancet.

[5]  M. G. Dube,et al.  Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. , 1994, Endocrinology.

[6]  J. Shi,et al.  Estradiol exerts neuroprotective effects when administered after ischemic insult. , 2000, Stroke.

[7]  H. Carswell,et al.  Estrogen is Neuroprotective via an Apolipoprotein E—Dependent Mechanism in a Mouse Model of Global Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  A. Dominiczak,et al.  Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. , 1999, Hypertension.

[9]  Patricia H. Petrozza,et al.  Gender-linked brain injury in experimental stroke , 1998 .

[10]  C. Viscoli,et al.  A clinical trial of estrogen-replacement therapy after ischemic stroke , 2002 .

[11]  A. Dominiczak,et al.  Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. , 2000, American journal of physiology. Heart and circulatory physiology.

[12]  Richard F. Thompson,et al.  17β-Estradiol Enhances NMDA Receptor-Mediated EPSPs and Long-Term Potentiation , 1999 .

[13]  J. Madans,et al.  Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. , 1993, Archives of internal medicine.

[14]  J. D. Neill,et al.  The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. , 1975, Endocrinology.

[15]  C. Culmsee,et al.  Neuroprotection by Estrogens in a Mouse Model of Focal Cerebral Ischemia and in Cultured Neurons: Evidence for a Receptor-Independent Antioxidative Mechanism , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  N. Weiland.  Glutamic acid decarboxylase messenger ribonucleic acid is regulated by estradiol and progesterone in the hippocampus. , 1992, Endocrinology.

[17]  C. Iadecola,et al.  Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. , 1999, Stroke.

[18]  B. Crain,et al.  17beta-estradiol reduces stroke injury in estrogen-deficient female animals. , 1999, Stroke.

[19]  L. Garcia-Segura,et al.  Estradiol prevents kainic acid‐induced neuronal loss in the rat dentate gyrus , 1998, Neuroreport.

[20]  T. Berger,et al.  17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. , 1999, Journal of neurophysiology.

[21]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[22]  P W Wilson,et al.  Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. , 1985, The New England journal of medicine.

[23]  Izumi Harukuni,et al.  Deleterious effect of β-estradiol in a rat model of transient forebrain ischemia , 2001, Brain Research.

[24]  Macrae I Mhairi.  New models of focal cerebral ischaemia. , 1992 .

[25]  B. Crain,et al.  Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. , 2001, Brain research.

[26]  P. Coyle,et al.  Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke‐prone rats (SHRSP) and Wistar Kyoto (WKY) rats. , 1983, Stroke.

[27]  S. Finklestein,et al.  Estradiol Protects against Ischemic Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  M. Bihoreau,et al.  Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. , 1996, Hypertension.

[29]  I Mhairi Macrae,et al.  New models of focal cerebral ischaemia. , 1992, British journal of clinical pharmacology.

[30]  D. Graham,et al.  Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[31]  A. Dominiczak,et al.  Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus , 1997, Nature Genetics.

[32]  H. Handa,et al.  Pathogenetic Similarity of Strokes in Stroke‐Prone Spontaneously Hypertensive Rats and Humans , 1976, Stroke.

[33]  R. Traystman,et al.  Estrogen-mediated neuroprotection after experimental stroke in male rats. , 1998, Stroke.

[34]  P. Hurn,et al.  Estrogen as a Neuroprotectant in Stroke , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  N. Schwartz,et al.  Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. , 1979, Biology of reproduction.